The prokineticin system: an interface between neural inflammation and pain

[1]  Yuquan Wei,et al.  Prokineticin 2 Plays a Pivotal Role in Psoriasis , 2016, EBioMedicine.

[2]  F. Birklein,et al.  Interaction of calcitonin gene related peptide (CGRP) and substance P (SP) in human skin , 2016, Neuropeptides.

[3]  Haruyasu Ito,et al.  Prokineticin 2 antagonist, PKRA7 suppresses arthritis in mice with collagen-induced arthritis , 2016, BMC Musculoskeletal Disorders.

[4]  P. Reeh,et al.  The prokineticin Bv8 sensitizes cutaneous terminals of female mice to heat , 2016, European journal of pain.

[5]  P. Sacerdote,et al.  Antagonism of the Prokineticin System Prevents and Reverses Allodynia and Inflammation in a Mouse Model of Diabetes , 2016, PloS one.

[6]  Lei Shi,et al.  Involvement of Spinal Bv8/Prokineticin 2 in a Rat Model of Cancer‐Induced Bone Pain , 2015, Basic & clinical pharmacology & toxicology.

[7]  V. Martinelli,et al.  Critical role for prokineticin 2 in CNS autoimmunity , 2015, Neurology: Neuroimmunology & Neuroinflammation.

[8]  S. Salvadori,et al.  PC1, a non-peptide PKR1-preferring antagonist, reduces pain behavior and spinal neuronal sensitization in neuropathic mice. , 2015, Pharmacological research.

[9]  L. Rodella,et al.  Controlling the activation of the Bv8/prokineticin system reduces neuroinflammation and abolishes thermal and tactile hyperalgesia in neuropathic animals , 2014, British journal of pharmacology.

[10]  A. Panerai.  Is migraine a disorder of the central nervous system? , 2013, Neurological Sciences.

[11]  T. Vanderah,et al.  Mechanisms of Bv8-induced biphasic hyperalgesia: Increased excitatory transmitter release and expression , 2012, Neuroscience Letters.

[12]  Gila Moalem-Taylor,et al.  The neuro-immune balance in neuropathic pain: Involvement of inflammatory immune cells, immune-like glial cells and cytokines , 2010, Journal of Neuroimmunology.

[13]  Y. Xiong,et al.  Prokineticin 2 suppresses GABA-activated current in rat primary sensory neurons , 2010, Neuropharmacology.

[14]  I. Screpanti,et al.  The chemokine Bv8/prokineticin 2 is up-regulated in inflammatory granulocytes and modulates inflammatory pain , 2009, Proceedings of the National Academy of Sciences.

[15]  H. Gascan,et al.  Prokineticin 1 induces CCL4, CXCL1 and CXCL8 in human monocytes but not in macrophages and dendritic cells. , 2008, European cytokine network.

[16]  P. Sacerdote,et al.  The prokineticin receptor agonist Bv8 decreases IL-10 and IL-4 production in mice splenocytes by activating prokineticin receptor-1 , 2008, BMC Immunology.

[17]  S. Maione,et al.  The prokineticin receptor agonist Bv8 increases GABA release in the periaqueductal grey and modifies RVM cell activities and thermoceptive reflexes in the rat , 2007, The European journal of neuroscience.

[18]  V. Vellani,et al.  Sensitization of Transient Receptor Potential Vanilloid 1 by the Prokineticin Receptor Agonist Bv8 , 2006, The Journal of Neuroscience.

[19]  P. Sacerdote,et al.  Bv8, the amphibian homologue of the mammalian prokineticins, induces a proinflammatory phenotype of mouse macrophages , 2006, British journal of pharmacology.

[20]  N. Bunnett,et al.  Impaired pain sensation in mice lacking prokineticin 2 , 2006, Molecular pain.

[21]  C. Fraser,et al.  PK1/EG‐VEGF induces monocyte differentiation and activation , 2005, Journal of leukocyte biology.

[22]  F. Peale,et al.  Bv8 and endocrine gland-derived vascular endothelial growth factor stimulate hematopoiesis and hematopoietic cell mobilization. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[23]  A. Colucci,et al.  Bv8, the amphibian homologue of the mammalian prokineticins, modulates ingestive behaviour in rats , 2004, British journal of pharmacology.

[24]  T. Giordano,et al.  Differential expression of the angiogenic factor genes vascular endothelial growth factor (VEGF) and endocrine gland-derived VEGF in normal and polycystic human ovaries. , 2003, The American journal of pathology.

[25]  D. Barra,et al.  Nociceptive sensitization by the secretory protein Bv8 , 2002, British journal of pharmacology.

[26]  Qun Zhou,et al.  Identification and Molecular Characterization of Two Closely Related G Protein-coupled Receptors Activated by Prokineticins/Endocrine Gland Vascular Endothelial Growth Factor* , 2002, The Journal of Biological Chemistry.

[27]  Michelle Y. Cheng,et al.  Prokineticin 2 transmits the behavioural circadian rhythm of the suprachiasmatic nucleus , 2002, Nature.

[28]  A I Basbaum,et al.  Impaired nociception and pain sensation in mice lacking the capsaicin receptor. , 2000, Science.

[29]  D. Barra,et al.  Bv8, a small protein from frog skin and its homologue from snake venom induce hyperalgesia in rats. , 1999, European journal of pharmacology.